Ｄｅｌｔａ－Ｆｌｙ Ｐｈａｒｍａ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4598/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2019/05/31 | 日証協 | 121,600株 | -7.18% | 25,700株 | +283.58% | 75,109株 | -13.27% | 4,112株 | -31.52% |
| 2019/05/24 | 日証協 | 131,000株 | -5.07% | 6,700株 | -66.67% | 86,602株 | -5.15% | 6,005株 | -74.56% |
| 2019/05/17 | 日証協 | 138,000株 | -8.85% | 20,100株 | +18.24% | 91,302株 | -1.72% | 23,600株 | +337.04% |
| 2019/05/10 | 日証協 | 151,400株 | -8.85% | 17,000株 | -81.93% | 92,902株 | -14.77% | 5,400株 | -91.13% |
| 2019/04/26 | 日証協 | 166,100株 | -23.63% | 94,100株 | +69.24% | 109,002株 | -15.38% | 60,900株 | +200% |
| 2019/04/19 | 日証協 | 217,500株 | -3.18% | 55,600株 | -5.28% | 128,807株 | -1.7% | 20,300株 | -30.24% |
| 2019/04/12 | 日証協 | 224,633株 | +2.32% | 58,700株 | +65.35% | 131,037株 | +0.33% | 29,100株 | +41.02% |
| 2019/04/05 | 日証協 | 219,533株 | +14.32% | 35,500株 | -61.63% | 130,603株 | +14.94% | 20,635株 | -54.29% |
| 2019/03/29 | 日証協 | 192,033株 | +145.88% | 92,532株 | -4.51% | 113,630株 | +112.36% | 45,144株 | -26.62% |
| 2019/03/22 | 日証協 | 78,100株 | +297.8% | 96,900株 | +3130% | 53,507株 | +211.05% | 61,525株 | +345.51% |
| 2019/03/15 | 日証協 | 19,633株 | -8.4% | 3,000株 | +172.73% | 17,202株 | -12.12% | 13,810株 | +316.72% |
| 2019/03/08 | 日証協 | 21,433株 | -4.88% | 1,100株 | -81.97% | 19,574株 | +5.79% | 3,314株 | -60.07% |
| 2019/03/01 | 日証協 | 22,533株 | +15.36% | 6,100株 | +64.86% | 18,502株 | +21.53% | 8,300株 | +453.33% |
| 2019/02/22 | 日証協 | 19,533株 | +2.09% | 3,700株 | +311.11% | 15,224株 | +0.01% | 1,500株 | +149.17% |
| 2019/02/15 | 日証協 | 19,133株 | +0.7% | 900株 | -82.47% | 15,222株 | +4.12% | 602株 | -81.24% |
| 2019/02/08 | 日証協 | 19,000株 | +6.15% | 5,133株 | -42.97% | 14,620株 | +19.82% | 3,209株 | -44.71% |
| 2019/02/01 | 日証協 | 17,900株 | -2.72% | 9,000株 | +181.25% | 12,202株 | -3.18% | 5,804株 | +241.21% |
| 2019/01/25 | 日証協 | 18,400株 | +14.29% | 3,200株 | +28% | 12,603株 | -8.69% | 1,701株 | -22.68% |
| 2019/01/18 | 日証協 | 16,100株 | -0.62% | 2,500株 | +150% | 13,802株 | +25.44% | 2,200株 | 0% |
※株式分割は考慮していませんのでご注意ください。
Page Top